PanGenomic Health Inc
Company Profile
Business description
PanGenomic Health Inc is focused on providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual. Along with its subsidiaries, it is developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support a user's specific health needs. Its initial focus is to provide information on personalized natural mental health solutions. The core products in production and under development by the company and its subsidiaries are a mobile app for consumers, Nara; an eCommerce website for consumers, Agenta Health; a real-world evidence platform for the complementary and alternative medicine market, Mindleap; and a clinical decision support platform for health practitioners, MUJN.
Contact
200 - 1575 W. Georgia Street
VancouverBCV6G 2V3
CANT: +1 604 725-4160
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 December 2026
Employees
Stocks News & Analysis
stocks
OpenAI is going public as the worst value among its peers
stocks
Wide moat healthcare leader remains undervalued
stocks
This US AI winner has been unstoppable. Is it time to sell?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,855.90 | 79.60 | -0.89% |
| CAC 40 | 8,218.24 | 26.05 | -0.32% |
| DAX 40 | 24,759.05 | 185.90 | -0.75% |
| Dow JONES (US) | 50,866.78 | 695.15 | -1.35% |
| FTSE 100 | 10,368.05 | 7.73 | 0.07% |
| HKSE | 24,961.95 | 291.45 | -1.15% |
| NASDAQ | 25,709.43 | 1,121.53 | -4.18% |
| Nikkei 225 | 66,588.12 | 882.57 | -1.31% |
| NZX 50 Index | 13,161.97 | 60.36 | 0.46% |
| S&P 500 | 7,383.74 | 200.57 | -2.64% |
| S&P/ASX 200 | 8,625.10 | 80.00 | -0.92% |
| SSE Composite Index | 4,027.74 | 30.04 | -0.74% |